The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC
Clinical trial NCT05904015 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05904015
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2026-12-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.